Biotech & Solar Blaze Into the Close: After-Hours Watchlist Heats Up
DENVER, Colo., Aug 15, 2025 (247marketnews.com)- As we approach the final stretch of Tuesday’s trading session, momentum is building across the biotech/biopharma and solar/energy sectors, with several names lining up for potential after-hours fireworks.
Biotech Breakouts: Watch These Into the Close
Still glowing from its FDA win earlier this week, Precigen (NASDAQ:PGEN) remains in play as PAPZIMEOS, the first and only approved therapy for recurrent respiratory papillomatosis (RRP), garners attention from analysts and institutions alike.
“With the landmark FDA approval of PAPZIMEOS and broad label, all adult RRP patients are now eligible for access to the first and only approved therapy that targets the root cause of the disease,” said CEO Helen Sabzevari.
As biotech funds reposition post-approval, $PGEN is attracting volume and looks poised for more upside on commercial launch speculation.
Call it quiet strength. LIXTE Biotech (NASDAQ:LIXT) has been ticking steadily higher, fueled by growing interest in LB-100, a first-in-class PP2A inhibitor in multiple Phase 1B/2 trials. The compound enhances tumor sensitivity to standard therapies, potentially transforming treatment for ovarian clear cell carcinoma, colon cancer, and soft tissue sarcoma.
LIXTE is positioning itself in the $200 billion global oncology market, as institutional players are starting to circle.
With multiple trial readouts expected in H2 2025, $LIXT could see an extended run if momentum carries through the close.
Earlier this week, INOVIO Pharmaceuticals (NASDAQ:INO) reported Q2 2025 results, reminding investors of its pipeline targeting HPV-related diseases, cancer, and infectious diseases. As DNA medicine technology matures, INO remains a speculative name to watch—particularly if volume picks up after-hours.
SRX Health Solutions, Healthcare Triangle (NASDAQ:HCTI), Karyopharm Therapeutics (NASDAQ:KPTI), IO Biotech (NASDAQ:IOBT), and Matinas BioPharma (NYSE:MTNB) are also attracting pockets of late-session attention as biopharma sentiment remains elevated.
Solar Sizzles: Earnings, Acquisitions & Big Guidance Boost Optimism
ARRAY Technologies (NASDAQ:ARRY) delivered a spark with its announcement of the successful acquisition of APA Solar, a top solar racking and structural solutions firm.
“This strategic acquisition strengthens ARRAY’s position as a global leader in renewable energy infrastructure…”
With the solar sector consolidating, $ARRY’s move is viewed as aggressively bullish. Traders are eyeing a potential after-hours guidance update or analyst upgrades as early as tomorrow.
A steady gainer into the afternoon, Shoals Technologies (NASDAQ:SHLS) is benefitting from sector-wide tailwinds and speculation about growing utility-scale demand. The company is rumored to be lining up multiple large project bids for Q3—fueling post-close watchlists.
Pioneer Power (NASDAQ:PPSI) came in hot with its Q2 2025 earnings, showing a 147% YoY revenue increase to $8.4 million and reaffirming full-year guidance.
“The second quarter was an excellent quarter for Pioneer,” said CEO Nathan Mazurek.
Non-GAAP operating income flipped positive at $218,000—a big turnaround from last year. Traders are watching for post-close institutional activity following the impressive top-line growth.
First Solar (NASDAQ:FSLR), Sunrun Inc. (NASDAQ:RUN), and SolarEdge Technologies (NASDAQ:SEDG) are also charging up late in the session, driven by tailwinds from clean energy policy updates and merger chatter in the solar ecosystem.
Wild Card: Perfect Moment (NYSE:PMNT). The high-end skiwear and lifestyle brand surprised with a 51% YoY revenue jump and a record gross margin of 60.4% in Q1 FY26.
“The launch of our spring/summer capsule, expansion of our style count, and the introduction of partnership revenues have further strengthened our brand positioning,” said President Jane Gottschalk.
While not a biotech or energy name, PMNT’s performance and e-commerce expansion success,
has it on radar for a potential after-hours re-rating.
After-Hours Setup Summary:
- Biotech Bull Run: $PGEN, $LIXT, $INO leading a health sector wave
- Solar Charge: $ARRY and $PPSI showing breakout potential
- Quiet Climbers: $HCTI, $MTNB, $KPTI, $SHLS under accumulation?
- PMNT as the style outlier with numbers to back it up
For additional 247marketnews.com and LIXT disclosure https://247marketnews.com/lixte-biotechnology/
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com